← Back to headlines
AbbVie and Genmab Announce Lymphoma Therapy Trial Setback
Pharmaceutical companies AbbVie and Genmab have announced a setback in a late-stage clinical trial for their lymphoma therapy. This development could impact the future availability and development of the treatment.
24 Jul, 11:54 — 24 Jul, 11:54
Sources
Showing 1 of 1 sources
Related Stories
Lionel Richie Hospitalized in ICU Following St. Louis Concert
1h ago
Anna Hazare admitted to Mumbai hospital's ICU with acute dehydration, kidney issue
6h ago
Ebola Outbreak in Democratic Republic of Congo Surpasses 6,000 Cases
8h ago
England Pharmacies to Offer Free Quick Cholesterol Screening Tests
16h ago